Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
NVIDIA
NVDA
Vale SA
VALE
KB Home
KBH
US Stock MarketDetailed Quotes
PRME Prime Medicine
- 2.840
- +0.245+9.44%
Close Feb 14 16:00 ET
- 2.850
- +0.010+0.35%
Post 20:01 ET
372.50MMarket Cap-1.38P/E (TTM)
2.900High2.660Low1.25MVolume2.660Open2.595Pre Close3.51MTurnover1.95%Turnover RatioLossP/E (Static)131.16MShares9.77052wk High1.97P/B182.15MFloat Cap2.25052wk Low--Dividend TTM64.14MShs Float21.730Historical High--Div YieldTTM9.25%Amplitude2.250Historical Low2.807Avg Price1Lot Size
About Prime Medicine Company
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.
Company Profile
SymbolPRME
Company NamePrime Medicine
Listing DateOct 20, 2022
Issue Price17.00
Founded2019
CEODr. Keith Gottesdiener, M.D.
MarketNASDAQ
Employees234
Fiscal Year Ends12-31
Address60 First Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02141-2300
Phone1-617-564-0013
Websitehttp://www.primemedicine.com
Company Executives
- Name
- Position
- Salary
- Dr. Keith Gottesdiener, M.D.
- President, Chief Executive Officer and Director
- 5.40M
- Dr. Jeremy Duffield
- Chief Scientific Officer
- 2.26M
- Dr. Ann L. Lee, PhD
- Chief Technical Officer
- 2.26M
- Richard H. Brudnick
- Chief Business Officer
- --
- Dr. Allan Reine, M.D.
- Chief Financial Officer
- --
- Carman Alenson
- Senior Vice President, Finance and Chief Accounting Officer
- --
- Dr. Meredith Goldwasser
- Senior Vice President, Strategy and Corporate Operations
- --
- Jeffrey D. Marrazzo
- Director
- 942.48K
- Dr. David P. Schenkein, M.D.
- Independent Director
- 455.46K
- Robert Taylor Nelsen
- Independent Director
- 445.46K
- Michael A Kelly
- Independent Director
- 454.46K
- Dr. Wendy K. Chung, M.D.,PhD
- Independent Director
- 451.96K
- Dr. Thomas Cahill
- Independent Director
- 451.96K
- Kaye Foster
- Independent Director
- 451.46K
- Andrew Anzalone, M.D.,PhD
- Head of Prime Editing Platform
- --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.